S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

QGEN

Qiagen NV (QGEN)

Qiagen NV

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:QGEN

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
01/04/2025	16:30	Business Wire	QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts	NYSE:QGEN	Qiagen NV
01/04/2025	16:30	Business Wire	QIAGEN führt QIAprep& Plasmodium Kit zur Verbesserung der Malariaforschung und -überwachung ein	NYSE:QGEN	Qiagen NV
31/03/2025	21:00	Business Wire	QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results	NYSE:QGEN	Qiagen NV
03/03/2025	17:00	Business Wire	QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing	NYSE:QGEN	Qiagen NV
03/03/2025	17:00	Business Wire	QIAGEN ergreift rechtliche Schritte zum Schutz seines geistigen Eigentums an QuantiFERON und seiner Innovationen in der Testung auf latente Tuberkulose	NYSE:QGEN	Qiagen NV
14/02/2025	08:05	Business Wire	QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region	NYSE:QGEN	Qiagen NV
06/02/2025	08:05	Business Wire	QIAGEN übertrifft Prognose für viertes Quartal 2024 mit solidem Wachstum	NYSE:QGEN	Qiagen NV
06/02/2025	08:05	Business Wire	QIAGEN delivers solid Q4 2024 growth ahead of outlook	NYSE:QGEN	Qiagen NV
05/02/2025	08:05	Business Wire	QIAGEN erhält positiven Gerichtsentscheid: Wichtiges QuantiFERON-TB Patent bestätigt	NYSE:QGEN	Qiagen NV
05/02/2025	08:05	Business Wire	QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent	NYSE:QGEN	Qiagen NV
17/01/2025	09:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:QGEN	Qiagen NV
17/01/2025	08:05	Business Wire	QIAGEN gibt Details zum Abschluss des synthetischen Aktienrückkaufs über bis zu rund $300 Mio. bekannt	NYSE:QGEN	Qiagen NV
17/01/2025	08:05	Business Wire	QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million	NYSE:QGEN	Qiagen NV
16/01/2025	00:13	Business Wire	QIAGEN N.V. to Release Results for Q4 2024 and Hold Webcast	NYSE:QGEN	Qiagen NV
14/01/2025	07:46	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:QGEN	Qiagen NV
13/01/2025	05:05	Business Wire	QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück	NYSE:QGEN	Qiagen NV
13/01/2025	05:05	Business Wire	QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase	NYSE:QGEN	Qiagen NV
10/01/2025	17:30	Business Wire	Tiefere Erkenntnisse aus biologischen Proben: QIAGEN erweitert digitales PCR-System QIAcuity um Multiplexing-Funktionen höherer Ordnung	NYSE:QGEN	Qiagen NV
10/01/2025	17:30	Business Wire	QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples	NYSE:QGEN	Qiagen NV
10/01/2025	08:05	Business Wire	QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care	NYSE:QGEN	Qiagen NV
10/01/2025	08:05	Business Wire	QIAGEN erhält U.S.-Zulassung für erstes QIAstat-Dx Mini-Panel für Magen-Darm-Infektionen zur Unterstützung der ganzjährigen ambulanten Versorgung	NYSE:QGEN	Qiagen NV
08/01/2025	08:05	Business Wire	QIAGEN liefert genomische Inhalte für britische Initiative zur Genomsequenzierung von 100.000 Neugeborenen	NYSE:QGEN	Qiagen NV
08/01/2025	08:05	Business Wire	QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content	NYSE:QGEN	Qiagen NV
13/12/2024	08:05	Business Wire	QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data	NYSE:QGEN	Qiagen NV
13/12/2024	08:05	Business Wire	QIAGEN führt KI-Erweiterung für Ingenuity Pathway Analysis zur automatisierten Interpretation biologischer Daten ein	NYSE:QGEN	Qiagen NV
06/12/2024	08:05	Business Wire	QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation	NYSE:QGEN	Qiagen NV
06/12/2024	08:05	Business Wire	QIAGEN erreicht Meilenstein: Über 1.000 platzierte EZ2 Connect-Systeme zur Probenvorbereitung treiben Laborautomatisierung voran	NYSE:QGEN	Qiagen NV
28/11/2024	22:00	Business Wire	QIAGEN stärkt QIAstat-Dx mit neuem Standort in Barcelona zur Wachstumsbeschleunigung bei Tests für Infektionskrankheiten und Präzisionsmedizin	NYSE:QGEN	Qiagen NV
28/11/2024	22:00	Business Wire	QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing	NYSE:QGEN	Qiagen NV
28/11/2024	08:05	GlobeNewswire Inc.	QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis	NYSE:QGEN	Qiagen NV

Showing the most relevant articles for your search:NYSE:QGEN

1 2 3 4 5 6 7 8 9 10 Next >>

Arras Minerals (QB)

Sigma Fin.nts09

Aquaron Acquisition

Agf Emerging Markets Cla...

Addtech AB (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions